Antibody-mediated glomerulonephritis in mice: The role of endotoxin, complement and genetic background

Clinical and Experimental Immunology

Volumn 133, Issue 3, 2003, Pages 326-333

  Robson, Michael G ^a,b   Cook, H T ^a   Pusey, C D ^a   Walport, M J ^a   Davies, K A ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b GUY S HOSPITAL   (United Kingdom)

Author keywords

Complement; Endotoxin; Genetic; Glomerulonephritis; Immune complex antibody; Mouse

Indexed keywords

ANTIBODY; COMPLEMENT; COMPLEMENT COMPONENT C1Q; ENDOTOXIN;

ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN ANTIBODY COMPLEX; ARTICLE; DISEASE PREDISPOSITION; FEMALE; GLOMERULONEPHRITIS; IMMUNE COMPLEX NEPHRITIS; INFECTION; INFLAMMATION; MALE; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES; COMPLEMENT C1Q; COMPLEMENT C2; COMPLEMENT FACTOR B; DISEASE SUSCEPTIBILITY; ENTEROTOXINS; FLUORESCENT ANTIBODY TECHNIQUE; GLOMERULONEPHRITIS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEUTROPHIL INFILTRATION; NEUTROPHILS;

EID: 0041859733     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2003.02233.x     Document Type: Article

References (30)

1. Rodicio JL. Idiopathic IgA nephropathy. Kidney Int 1984; 25:717-29.
2. Nakamoto Y, Asana Y, Dohi K et al. Primary IgA glomerulonephritis and Schonlein-Henoch Purpura nephritis: clinicopathological and immunohistological characteristics. Q J Med 1978; 188:495-516.
3. Frimat L, Briançon S, Hestin D et al. IgA nephropathy, prognostic classification of end-stage renal failure. Nephrol Dial Transplant 1997; 12:2569-75.
4. Rees AJ, Lockwood CM, Peters DK. Enhanced allergic tissue injury in Goodpasture's syndrome by intercurrent bacterial infection. Br Med J 1977; 2:723-6.
5. Unanue ER, Dixon FJ. Experimental glomerulonephritis. V. Studies on the interaction of nephrotoxic antibodies with tissues of the rat. J Exp Med 1965; 121:697.
6. Cochrane CG, Unanue ER, Dixon FJ. A Role of polymorphonuclear leukocytes and complement in nephrotoxic nephritis. J Exp Med 1965; 122:99-119.
7. Tomosugi NI, Cashman SJ, Hay H et al. Modulation of antibody-mediated glomerular injury in vivo by bacterial lipopolysaccharide, tumour necrosis factor, and II-1. J Immunol 1989; 142:3083-90.
8. Karkar AM, Rees AJ. Influence of endotoxin contamination on anti-GBM antibody induced glomerular injury in rats. Kidney Int 1997; 52:1579-83.
9. Assmann KJ, Tangelder MM, Lange WP et al. Anti-GBM nephritis in the mouse: severe proteinuria in the heterologous phase. Virchows Arch A Pathol Anat Histopathol 1985; 406:285-99.
10. Unanue ER, Dixon FJ. Experimental glomerulonephritis, immunological events and pathogenetic mechanisms. Adv Immunol 1967; 6:1-90.
11. Hammer DK, Dixon FJ. Experimental glomerulonephritis. III. Immunologic events in the pathogenesis of nephrotoxic seum nephritis in the rat. J Exp Med 1963; 117:1019-34.
12. Unanue ER, Dixon FJ. Experimental glomerulonephritis. IV. Participation of complement in nephrotoxic serum nephritis. J Exp Med 1964; 119:965.
13. Tipping PG, Huang XR, Berndt MC et al. A role for P selectin in complement-independent neutrophil-mediated glomerular injury. Kidney Int 1994; 46:79-88.
14. Schrijver G, Assmann KJ, Bogman MJ et al. Antiglomerular basement membrane nephritis in the mouse. Study on the role of complement in the heterologous phase. Laboratory Invest 1988; 59:484-91.
15. Herbert M, Takano T, AP et al. Acute nephrotoxic serum nephritis in complement knockout mice, relative roles of the classical and alternate pathways in neutrophil recruitment and proteinuria. Nephrol Dial Transplant 1998; 13:2799-803.
16. Sheerin NS, Springall T, Carroll MC et al. Protection against anti-glomerular basement membrane (GBM)-mediated nephritis in C3-and C4-deficient mice. Clin Exp Immunol 1997; 110:403-9.
17. Tang T, Rosenkranz A, Assmann KJM et al. A role for Mac-1 (CDIIb/CD18) in immune complex-stimulated neutrophil function in vivo. Mac-1 deficiency abrogates sustained Fcgamma receptor-dependent neutrophil adhesion and complement-dependent proteinuria in acute glomerulonephritis. J Exp Med 1997; 186:1853-63.
18. Taylor PR, Nash JT, Theodoridis E et al. A targeted disruption of the murine complement factor B gene resulting in loss of expression of three genes in close proximity, factor B, C2, and D17H6S45. J Biol Chem 1998; 273:1699-704.
19. Botto M, Dell'Agnola C, Bygrave AE et al. Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat Genet 1998; 19:56-9.
20. Matsumoto M, Fukuda W, Circolo A et al. Abrogation of the alternative complement pathway by targeted deletion of murine factor B. Proc Natl Acad Sci USA 1997; 94:8720-5.
21. Robson MG, Cook HT, Botto M et al. Accelerated nephrotoxic nephritis is exacerbated in C1q-deficient mice. J Immunol 2001; 166:620-8.
22. Coxon A, Cullere X, Knight S et al. Fc gamma RIII mediates neutrophil recruitment to immune complexes, a mechanism for neutrophil accumulation in immune-mediated inflammation. Immunity 2001; 14:693-704.
23. Ang C, Savige J, Dawborn J et al. Anti-glomerular basement membrane (GBM)-antibody-mediated disease with normal renal function. Nephrol Dial Transplant 1998; 13:935-9.
24. Kalluri R, Torre A, Shield III CF et al. Identification of alpha3, alpha4, and alpha5 chains of type IV collagen as alloantigens for Alport posttransplant anti-glomerular basement membrane antibodies. Transplantation 2000; 69:679-83.
25. Karkar AM, Koshino Y, Cashman SJ et al. Passive immunization against tumour necrosis factor-alpha (TNF-alpha) and IL-1 beta protects from LPS enhancing glomerular injury in nephrotoxic nephritis in rats. Clin Exp Immunol 1992; 90:312-8.
26. Karkar AM, Tam FW, Steinkasserer A et al. Modulation of antibody-mediated glomerular injury in vivo by IL-1ra, soluble IL-1 receptor, and soluble TNF receptor. Kidney Int 1995; 48:1738-46.
27. Karkar AM, Smith J, Pusey CD. Prevention and treatment of experimental crescentic glomerulonephritis by blocking tumour necrosis factor-alpha. Nephrol Dial Transplant 2001; 16:518-24.
28. Hibbs ML, Tarlinton DM, Armes J et al. Multiple defects in the immune system of Lyn-deficient mice, culminating in autoimmune disease. Cell 1995; 83:301-11.
29. Chen Z, Koralov SB, Kelsoe G. Complement C4 inhibits systemic autoimmunity through a mechanism independent of complement receptors CR1 and CR2. J Exp Med 2000; 192:1339-52.
30. White P, Liebhaber SA, Cooke NE. 129X1/SvJ mouse strain has a novel defect in inflammatory cell recruitment. J Immunol 2002; 168:869-74.